Way too many posts about darkout. Just ignore him and move on.
Let's dicusa upcoming activities, stock prospects, and market momentum!
And how are they going to save lives by annoying people on other stock message boards, virtually assuring that the ones they are annoying will never ever own VICL under any circumstances?
How does that help exactly?
Shorts lie about it because they have no real arguments to make based on their own merits. Therefore they twist normal options exercise combined with automatic selling, which is the normal part of any public companies executive compensation plan, and lie about it - claiming insiders are dumping.
I guess the short seller could simply be that incredibly stupid & not have any clue whatsoever about how executive compensation works, but if that's the case, they shouldn't be in stocks at all.
Just ignore the loser short seller. If his short selling argument had any merit he wouldn't have to misrepresent options-exercising by executives as insider dumping. He lies because he can't make a credible argument.
1-short seller with no job papers this msg board from his Mom's basement where he lives. Pathetic.
The board was full of blabber mouths claiming that these great companies had NO profits and therefore shouldn't be invested in.
The drugs/profits are coming for ISIS and when the do arrive, they will be massive.
LOTS of outstanding companies had negative earnings that boomed to massive returns over time: Google, Amazon, Apple, Microsoft - just to name a few.
So you've sold all your shares, or never bought any? Or are you short?
Just curious. How many companies have you started from scratch and build to a $1B+ market cap? I just want to be sure we are on the same level before we continue. Otherwise you are just a whiney wanna-be who is jealous of other people's success.
To the moron who doesn't understand executive compensation, we (shareholders) would much rather executives get compensated in terms of stock rather than cash so their fate is tied with ours.
Also, think about the alternative, the drug didn't kill the mice, or create massive rumors, etc.
So showing a drug is safe and effective in mice sure beats the opposite.
Any idea when that secretive deal may be announced? Just curious if we are weeks, months, or years away.
A small number of patients isn't necessarily an issue. Look at how AEGR did with their orphan drug. The stock soared from $12 to $100+ then came back down to $20 (as the estimates of the number of patients was higher than what they were able to achieve). Still, lots of money to be made.
It all depends on where you got in. Is it going back to $6 or to $30?